Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0111
0.00 (0.00%)
Jul 21, 2026, 9:30 AM EST
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $53.89 thousand as of July 23, 2026. Its market cap has decreased by -93.06% in one year.
Market Cap
53.89K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 53.89K, a decrease of -99.94%. That is a compound annual growth rate of -49.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 53.89K | 5,449.85% |
| Dec 31, 2025 | 971.00 | -99.95% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synairgen | 110.27K |
| Nascent Biotech | 103.71K |
| Ocean Biomedical | 92.95K |
| Vincerx Pharma | 79.04K |
| Affymax | 74.49K |
| Scorpius Holdings | 73.37K |
| U.S. Stem Cell | 66.15K |
| PaxMedica | 63.14K |